Beth Hoffman

Company: Origami Therapeutics, Inc.

Job title: Founder & Chief Executive Officer

Seminars:

Panel: Navigating the 3D Tissue Modelling Landscape Focusing on Model Adoption & Current Regulatory Frameworks 9:00 am

Discussing the need for common benchmarks and standards to ensure comparability and reproducibility across different laboratories and research settings Sharing insights and experiences from industry leaders on best practices, to bring these technologies internally by making a business case Addressing the current regulatory landscape for accepting data from 3D tissue models in drug developmentRead more

day: Day One